Home>Topics>Companies>Reckitt Benckiser

Reckitt Benckiser

  1. All
  2. Commentary
  3. Fund Reports
  4. ETF Reports
  5. Headlines
  1. Aurelius to buy Scholl from Reckitt Benckiser

    Headlines

    Mon, 21 Jul 2014

    German private equity firm Aurelius has agreed to buy Reckitt Benckiser 's ( OTCPK:RBGLY ) Scholl shoe business. The company is expecting the brand to expand internationally and maintain growth

  2. Aurelius buys Scholl shoe business from Reckitt Benckiser

    Headlines

    Mon, 21 Jul 2014

    FRANKFURT, July 21 (Reuters) - German private equity firm Aurelius said on Monday it is buying Reckitt Benckiser 's Scholl shoe business in its efforts to expand internationally, betting on the brand's growth potential.

  3. BRIEF-Aurelius to acquire Scholl's footwear division from Reckitt Benckiser Group plc

    Headlines

    Mon, 21 Jul 2014

    July 21 (Reuters) - Aurelius AG : * Says to acquire Scholl's footwear division from Reckitt Benckiser Group plc * Says completion is scheduled for Q3 2014 * Source text for Eikon * Further company coverage

  4. Lightlake engages contract manufacturer for opioid overdose treatment

    Headlines

    Wed, 9 Jul 2014

    reverses the overdose of prescription and illicit opioids. An intranasal delivery system is under development. Reckitt Benckiser has teamed up with AntiOp to develop a nasal delivery product as well. Post your comment!

  5. Reckitt Buys K-Y Brand in Move That Will Complement Existing Portfolio

    Commentary

    Mon, 10 Mar 2014

    Reckitt Benckiser today announced the acquisition of the global rights to the K-Y brand from Johnson & Johnson for an undisclosed amount. The

  6. Reckitt to Explore Strategic Alternatives for Pharmaceuticals Operations; Shares Fairly Valued

    Commentary

    Tue, 22 Oct 2013

    Reckitt Benckiser ’s third-quarter sales update showcased modest top-line underlying growth (3% in total, 5% excluding the pharmaceuticals segment

  7. Lingering Cold and Flu Season a Plus for Reckitt but Competitive Pressures Remain; Shares a Bit Rich

    Commentary

    Mon, 29 Jul 2013

    A strong cold and flu season propped up Reckitt Benckiser 's RB . first-half results (underlying sales up 6% year over year) . However, adjusted operating margins slipped 80 basis points

  8. Strong Cold and Flu Season Led to Healthy Top Line at Reckitt; Shares Not Overly Attractive

    Commentary

    Mon, 22 Apr 2013

    Despite the ills faced by consumers, Reckitt Benckiser RB . actually benefited from the strong cold and flu season, as evidenced in its first-quarter trading update. Adjusting for acquisitions

  9. Reckitt's Move to Get Healthy is Gaining Traction, But the Shares are Not a Bargain

    Commentary

    Wed, 13 Feb 2013

    In line with the plan laid out a year ago, Reckitt Benckiser ’s RB . focus on expanding in health and hygiene (particularly in emerging regions) is taking shape, supporting our narrow economic

  10. Reckitt Avoids a War for Schiff as Bayer Steps Aside

    Commentary

    Thu, 22 Nov 2012

    launching a $42 per share tender offer (a total price tag of $1.4 billion) for Schiff Nutrition International, Reckitt Benckiser RB . announced the two firms signed a merger agreement, and as such, we now believe a deal is imminent. This follows

« Prev123Next »
Content Partners